This translational work is typically designed to investigate clinically relevant subsets of cancer, such as platinum sensitive or platinum resistant tumors, or in PDX models with specific tumor genotypes such as BRCA1- or BRCA2-mutant models. The gene discussed is BRCA2; the disease is cancer.